AF
Insider
Andrew J. Fromkin
DirectorAndrew J. Fromkin (Director) filed 2 Form 4 reports in the trailing twelve months (0 purchases, 2 sales), most often in Immunovant, Inc. (IMVT). The largest single filing was $7.4M of IMVT (221,951 sh across 2 lots, as filed), executed May 28.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
2
0 buys · 2 sells
Median delay
–
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$7.9M
shares × price, as filed
Last traded
May 28
Filed May 29
Median ADV $75.6M across their filed names
Open performance→Volume by month
Buys $0
Sells $8.0M
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
2 filings
Sector per market data · by filing · past 12 months
Most traded names
IMVTRecent filings
IMVTSALE
Immunovant, Inc.
View filing →
$7.4M221,951 sh across 2 lots
Exec May 28
Filed May 29 · 5:30 PM ET IMVTSALE Immunovant, Inc. View filing → $448K
19,351 sh × $23.14
Exec Dec 1 2025
Filed Dec 3 2025 · 5:30 PM ET IMVTSALE Immunovant, Inc. View filing → $129K
6,616 sh × $19.52
Exec Mar 7 2025
Filed Mar 11 2025 · 5:30 PM ET